Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Cited by (1,002)

Items 901–1,000 of 1,002

1. Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity
   Stuart G. Tangye, Giorgia Bucciol, Isabelle Meyts · 2021 · Current Opinion in Allergy and Clinical Immunology
2. Prognostic nutritional index as indicator of immune nutritional status of patients with COVID-19
   İskender Ekinci, Hafize Uzun, İrem Kıraç Utku, Hanişe Ozkan, Mitat Büyükkaba, Ahmet Çınar, Murat Akarsu, Abdülbaki Kumbasar, Ömür Tabak · 2021 · International Journal for Vitamin and Nutrition Research
3. Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma
   Xiaoyan Ding, Nan Ye, Minyue Qiu, Hongxia Guo, Junjie Li, Xiaoyang Zhou, Maocheng Yang, Jing Xi, Yongjie Liang, Yuanxin Gong et al. · 2022 · Chemico-Biological Interactions
4. Association Between Vitamin D Levels and Inflammatory Markers in COVID-19 Patients: A Meta-Analysis of Observational Studies
   Robert Hopefl, Mohamed Ben‐Eltriki, Subrata Deb · 2022 · Journal of Pharmacy & Pharmaceutical Sciences
5. Targeting tumor-associated macrophages for cancer immunotherapy
   Xu Cao, Seigmund Wai Tsuen Lai, Siqi Chen, Sadira Wang, Mingye Feng · 2022 · International review of cytology
6. Therapy Targets SARS-CoV-2 Infection-Induced Cell Death
   Zhoujie Zhu, Jiayi Shi, Long Li, Jinling Wang, Yufen Zhao, Huabin Ma · 2022 · Frontiers in Immunology
7. The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation
   Sriganesh B. Sharma, William James Melvin, Christopher O. Audu, Monica Bame, Nicole M. Rhoads, Wei-Sheng Wu, Yogendra M. Kanthi, Jason S. Knight, Reheman Adili, Michael A. Holinstat et al. · 2022 · Blood
8. Venous thromboembolism in viral diseases: A comprehensive literature review
   Nasibeh Zerangian, Gisou Erabi, Mohadeseh Poudineh, Kosar Monajjem, Maryam Diyanati, Maryam Khanlari, Amirmohammad Khalaji, Diba Allafi, Arezoo Faridzadeh, Arian Amali et al. · 2023 · Health Science Reports
9. Distinct Transcriptional and Functional Differences of Lung Resident and Monocyte-Derived Alveolar Macrophages During the Recovery Period of Acute Lung Injury
   Fei Hou, Huan Wang, Kun Zheng, Wenting Yang, Kun Xiao, Zihan Rong, Junjie Xiao, Jing Li, Baihe Cheng, Li Tang et al. · 2023 · Immune Network
10. Frailty after COVID ‐19: The wave after?
    Maximilian König, Maik Gollasch, Yulia Komleva · 2023 · Aging Medicine
11. Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease
    Chunsong Hu · 2024 · Natural Products and Bioprospecting
12. Systems Pharmacology and Verification of ShenFuHuang Formula in Zebrafish Model Reveal Multi-Scale Treatment Strategy for Septic Syndrome in COVID-19
    Tengwen Liu, Yuhong Guo, Jingxia Zhao, Shasha He, Yunjing Bai, Ning Wang, Yan Lin, Qingquan Liu, Xiaolong Xu · 2020 · Frontiers in Pharmacology
13. Peptide Antidotes to SARS-CoV-2 (COVID-19)
    Andre Watson, Leonardo M. R. Ferreira, Peter K. Hwang, Jinbo Xu, Robert Michael Stroud · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
14. Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits
    Jiao Zhou, Chunxia Li, Meng Lu, Gaoyue Jiang, Shanze Chen, Huihui Li, Kefeng Lu · 2024 · PLoS Biology
15. SARS-CoV-2/COVID-19: a primer for cardiologists
    Antoine A.F. de Vries · 2020 · Netherlands Heart Journal
16. A brief discussion of the benefit and mechanism of vitamin D supplementation on coronavirus disease 2019
    Emanuele Cereda, Laura Bogliolo, Ludovico De Stefano, Riccardo Caccialanza · 2020 · Current Opinion in Clinical Nutrition & Metabolic Care
17. The coronavirus disease 2019 and effect on liver function: a hidden and vital interaction beyond the respiratory system
    Parastoo Hosseini, Shervin Afzali, Mohammadreza Karimi, Milad Zandi, Arghavan Zebardast, Tayebeh Latifi, Alireza Tabibzadeh, Akam Ramezani, Armin Zakeri, Amirmohammad Zakeri et al. · 2021 · Reviews in Medical Microbiology
18. Hepcidin Increases Cytokines in Alzheimer’s Disease and Down’s Syndrome Dementia: Implication of Impaired Iron Homeostasis in Neuroinflammation
    Animesh Alexander Raha, Seyedeh Deniz Ghaffari, James W. Henderson, Subhojit Chakraborty, Kieren S. J. Allinson, Robert Paul Friedland, Anthony John Holland, Shahid H. Zaman, Elizabeta Blagoja Mukaetova-Ladinska, Ruma Raha‐Chowdhury · 2021 · Frontiers in Aging Neuroscience
19. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients
    Yi Chen, Ping Li, Yibo Ding, Miao Liu, Leijie Liu, Bo Yi, Ting Wu, Hongjun Dong, Xuying Lao, Keqing Ding et al. · 2021 · Journal of Infection and Public Health
20. Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome
    Hanfei Guo, Lei Qian, Jiuwei Cui · 2021 · Cancer Biology and Medicine
21. Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study
    Blandine Monel, Delphine Planas, Ludivine Grzelak, Nikaïa Smith, Nicolas Robillard, Isabelle Staropoli, Pedro Gonçalves, Françoise Porrot, Florence Guivel‐Benhassine, Nathalie Demory Guinet et al. · 2021 · EBioMedicine
22. Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence
    Riccardo Sarzani, Francesco Spannella, Federico Giulietti, Chiara Di Pentima, Piero Giordano, Andrea Giacometti · 2021 · Internal and Emergency Medicine
23. Unraveling Muscle Impairment Associated With COVID-19 and the Role of 3D Culture in Its Investigation
    Maria Luiza Seixas, Lucas Pari Mitre, Shahin Shams, Gabriel Barbugian Lanzuolo, Cynthia Silva Bartolomeo, Eduardo Alexandre Silva, Carla Máximo Prado, Rodrigo Portes Ureshino, Roberta Sessa Stilhano · 2022 · Frontiers in Nutrition
24. Immune responses to SARS-CoV-2 in dialysis and kidney transplantation
    Chiara Cantarelli, Andrea Angeletti, Laura Perin, Luis Sanchez Russo, Gianmarco Sabiu, Manuel Alfredo Podestà, Paolo Cravedi · 2022 · Clinical Kidney Journal
25. Single cell meta-analysis of EndMT and EMT state in COVID-19
    Lanlan Zhang, Chuang Tang, Min Zhang, Xia Tong, Yingying Xie, Ruitong Yan, Xiangjun Wang, Xin Zhang, Dan Liu, Shasha Li · 2022 · Frontiers in Immunology
26. Central role of purinergic receptors with inflammation in neuropathic pain-related macrophage-SGC-neuron triad
    Runan Yang, Junpei Du, Lin Li, Xiumei Xu, Shangdong Liang · 2023 · Neuropharmacology
27. Anti-HERV-K Drugs and Vaccines, Possible Therapies against Tumors
    Sepideh Hosseiniporgham, Leonardo Antonio Sechi · 2023 · Vaccines
28. Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19
    Bader M. Jarai, Zachary S. Stillman, Kartik Bomb, April M. Kloxin, Catherine A. Fromen · 2020 · ACS Biomaterials Science & Engineering
29. ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion
    Qiangmin Zhang, Julia V. Gefter, W. Bruce Sneddon, Tatyana Mamonova, Peter A. Friedman · 2021 · iScience
30. Nervous System-Systemic Crosstalk in SARS-CoV-2/COVID-19: A Unique Dyshomeostasis Syndrome
    Harnadar Anand, Victoria Ende, Gurinder K. Singh, Irfan Qureshi, Timothy Q. Duong, Mark F. Mehler · 2021 · Frontiers in Neuroscience
31. IL‐34 deficiency impairs FOXP3+ Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasis
    Antoine Freuchet, Apolline Salama, Séverine Bézie, Laurent Tesson, Séverine Remy, Romain Humeau, Hadrien Règue, Céline Sérazin, Léa Flippe, Pärt Peterson et al. · 2022 · Clinical and Translational Medicine
32. High expression of angiotensin-converting enzyme-2 (ACE2) on tissue macrophages that may be targeted by virus SARS-CoV-2 in COVID-19 patients
    Xiang Hui Song, Wei Hu, Haibo Yu, Laura Zhao, Yeqian Zhao, Yong Zhao · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
33. Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes
    Dobosh, Brian, Zandi, Keivan, Giraldo, Diego Moncada, Goh, Shu Ling, Musall, Kathryn, Aldeco, Milagros, LeCher, Julia, Giacalone, Vincent D., Yang, Junkai, Eddins, Devon J. et al. · 2022 · Cell Reports
34. Exploring the mechanism and crosstalk between IL-6 and IL- 1β on M2 macrophages under metabolic stress conditions
    Shawna Yadav, Anusha Prasannan, Kaliyamurthi Venkatachalam, Ambika Binesh · 2025 · Cytokine
35. Maternal and Perinatal Outcomes in Patients with Suspected COVID-19 and Their Relationship with a Negative RT-PCR Result
    Yolanda Cuñarro-López, Óscar Cano-Valderrama, Pilar Pintado Recarte, Ignacio Cueto-Hernández, Blanca González Garzón, Santiago García‐Tizón Larroca, Julia Buján, Ángel Asúnsolo, Miguel Angel Ortega, Juan Antonio De León-Luis · 2020 · Journal of Clinical Medicine
36. Murine-β-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV2
    Debanjana Chakravarty, Jayasri Das Sarma · 2021 · Journal of NeuroVirology
37. Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia
    Alex R. Schuurman, Tom D. Y. Reijnders, Anno Saris, Ivan Ramirez‐Moral, Michiel Schinkel, Justin de Brabander, Christine C. A. van Linge, Louis Vermeulen, Brendon P. Scicluna, Willem Joost Wiersinga et al. · 2021 · eLife
38. Umbilical cord blood-derived microglia-like cells to model COVID-19 exposure
    Steven D. Sheridan, Jessica M. Thanos, Rose M. De Guzman, Liam T. McCrea, Joy E. Horng, Ting Fu, Carl M. Sellgren, Roy H. Perlis, Andrea G. Edlow · 2021 · Translational Psychiatry
39. Hemophagocytic lymphohistiocytosis, a new cause of death during ‘post-acute COVID-19 syndrome?’ A case report
    Elie Naous, B.M. Nassani, César Yaghi, Fadi louis Nasr, R. Medlej · 2021 · Journal of Hematopathology
40. Pattern Recognition Proteins: First Line of Defense Against Coronaviruses
    Carlos Alberto Labarrere, Ghassan S. Kassab · 2021 · Frontiers in Immunology
41. Standardized Extract of Asparagus officinalis Stem Attenuates SARS-CoV-2 Spike Protein-Induced IL-6 and IL-1β Production by Suppressing p44/42 MAPK and Akt Phosphorylation in Murine Primary Macrophages
    Ken Shirato, Jun Takanari, Takako Kizaki · 2021 · Molecules
42. An insight to the therapeutic potential of algae-derived sulfated polysaccharides and polyunsaturated fatty acids: Focusing on the COVID-19
    Kobra Ziyaei, Zahra Ataie, Majid Mokhtari, Kelvin Adrah, Mohammad Ali Daneshmehr · 2022 · International Journal of Biological Macromolecules
43. Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival
    Lara Gibellini, Sara De Biasi, Marianna Meschiari, Licia Gozzi, Annamaria Paolini, Rebecca Borella, Marco Mattioli, Domenico Lo Tartaro, Lucia Fidanza, Anita Neroni et al. · 2022 · Frontiers in Immunology
44. Carotid Enadrterectomy for Thrombosis of the Internal Carotid Artery in Patients With COVID-19
    Anton Nikolaevich Kazantsev, M.R. Karkayeva, A.P. Tritenko, Alexander Vladimirovich Korotkikh, Жарова Алина Сергеевна, К. П. Черных, Goderzi Sh. Bagdavadze, Roman Yu. Lider, Y.V. Kazantseva, K. L. Zakharova et al. · 2022 · Current Problems in Cardiology
45. Evidence underscoring immunological and clinical pathological changes associated with Sarcoptes scabiei infection: synthesis and meta-analysis
    Christina Næsborg‐Nielsen, Vicky Wilkinson, Natalia Mejia-Pacheco, Scott Carver · 2022 · BMC Infectious Diseases
46. Publication trends of research on COVID-19 and host immune response: A bibliometric analysis
    Yun Qiang Xia, Ren-qi Yao, Pengyue Zhao, Zhengbo Tao, Liyu Zheng, Huiting Zhou, Yong-ming Yao, Xuemin Song · 2022 · Frontiers in Public Health
47. The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity
    Sterre L. Siekman, Tamás Pongrácz, Wenjun Wang, Jan Nouta, Peter G. Kremsner, Pedro Vieira Da Silva-Neto, Meral Esen, Andrea Kreidenweiss, Jana Held, Átila Alexandre Trapé et al. · 2022 · Frontiers in Immunology
48. Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs
    Jaroslav Pelisek, Benedikt Reutersberg, Urs F. Greber, Alexander Zimmermann · 2022 · Clinical Science
49. Transcription factor Nrf2 as a potential therapeutic target for COVID-19
    Yifan Wang, Jing Ma, Yongfang Jiang · 2022 · Cell Stress and Chaperones
50. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential
    Hui Xiang, Qiping Liu · 2022 · World Journal of Gastroenterology
51. Increased Alveolar Epithelial Damage Markers and Inflammasome-Regulated Cytokines Are Associated with Pulmonary Superinfection in ARDS
    Konrad Peukert, Andrea Sauer, Benjamin Seeliger, Caroline Feuerborn, Mario Fox, Susanne Schulz, Lennart C. Wild, Valeri Borger, Patrick Schuss, Matthias B. Schneider et al. · 2023 · Journal of Clinical Medicine
52. Ferroptosis and multi-organ complications in COVID-19: mechanisms and potential therapies
    Qi Li, Zeyuan Chen, Xiaoshi Zhou, Guolin Li, Changji Zhang, Yong Yang · 2023 · Frontiers in Genetics
53. Extracellular Vesicle‐Inspired Therapeutic Strategies for the COVID‐19
    Ziwei Hu, Wei Wang, Ying Lin, Hui Guo, Yiwen Chen, Junjie Wang, Feng Yu, Lang Rao, Zhijin Fan · 2024 · Advanced Healthcare Materials
54. Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients
    Xin Huang, Chaobin He, Xin Hua, Anna Kan, Shuxin Sun, Jun Wang, Shengping Li · 2020 · International Journal of Biological Sciences
55. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm
    Michel Desjarlais, Maëlle Wirth, Isabelle Lahaie, Pakiza Ruknudin, Pierre Hardy, Alain Rivard, Sylvain Chemtob · 2020 · Frontiers in Pharmacology
56. B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceased
    Jana Ihlow, Edward Georg Michaelis, Selina Greuel, Verena Heynol, Annika Lehmann, Helena Radbruch, Jenny Meinhardt, Florian Miller, Hermann Herbst, Victor M. Corman et al. · 2021 · International Journal of Infectious Diseases
57. Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective
    Yashwant Kumar Ratre, Namrata Kahar, Lakkakula VKS Bhaskar, Antaripa Bhattacharya, Henu Kumar Verma · 2021 · 3 Biotech
58. The human G protein‐coupled ATP receptor P2Y 11 is a target for anti‐inflammatory strategies
    Georg Gruenbacher, Hubert Gander, Gerhard Dobler, Andrea Rahm, Dominik Klaver, Martin Thurnher · 2021 · British Journal of Pharmacology
59. Interdisciplinary Approaches to COVID-19
    Negar Moradian, Marjan Moallemian, Farnaz Delavari, Constantine Sedikides, Carlos A. Camargo, Pedro J. Torres, Armin Sorooshian, S. Paktinat Mehdiabadi, Juan Jose Nieto, Stéphane Bordas et al. · 2021 · Advances in experimental medicine and biology
60. An Impaired Inflammatory and Innate Immune Response in COVID-19
    Sung Ho Park · 2021 · Molecules and Cells
61. Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI
    Fabian Bohländer, Dennis Riehl, Sabrina Weißmüller, Marcus Gutscher, Jörg Schüttrumpf, Stefanie Faust · 2021 · Frontiers in Immunology
62. Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients
    Silvia Lucena Lage, Joseph M. Rocco, Elizabeth Laidlaw, Adam W. Rupert, Frances Galindo, Anela Kellogg, Princy N. Kumar, Rita Poon, Glenn W. Wortmann, Andrea Lisco et al. · 2022 · Frontiers in Immunology
63. Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
    Esther Silberberg, János G. Filep, Amiram Ariel · 2022 · Frontiers in Immunology
64. Integrin α 5 β 1 contributes to cell fusion and inflammation mediated by SARS-CoV-2 spike via RGD-independent interaction
    Heng Zhang, Zhengli Wang, Huong T. T. Nguyen, Abigail J. Watson, Qifang Lao, An Li, Jieqing Zhu · 2023 · Proceedings of the National Academy of Sciences
65. Macrophage-augmented intestinal organoids model virus-host interactions in enteric viral diseases and facilitate therapeutic development
    Guige Xu, Jiangrong Zhou, Kuan Liu, Yining Wang, Theano Tsikari, Qin Fang, Francijna E. van den Hil, Patrick P.C. Boor, Ibrahim Ayada, Annemarie C. de Vries et al. · 2025 · Nature Communications
66. Is macrophages heterogeneity important in determining COVID-19 lethality?
    Pasquale Pagliaro · 2020 · Medical Hypotheses
67. Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19
    Rahul Kumar, Michael H. Lee, Claudia Silva Mickael, Biruk Kassa, Qadar Pasha, Rubin M. Tuder, Brian B. Graham · 2020 · ERJ Open Research
68. Parallels in the Pathogenesis of SARS-CoV-2 and M. Tuberculosis : a synergistic or Antagonistic Alliance?
    Kesego Tapela, Charles Ochieng’ Olwal, Osbourne Quaye · 2020 · Future Microbiology
69. Advances of nanomaterials‐based strategies for fighting against COVID‐19
    Chunxi Zeng, Xucheng Hou, Margaret Bohmer, Yizhou Dong · 2021 · Open Research (University of Surrey)
70. Myocardial Injury in COVID-19 Patients: Association with Inflammation, Coagulopathy and In-Hospital Prognosis
    Víctor Arévalos, Luis Ortega‐Paz, Juan José Rodríguez-Arias, Margarita Calvo, Leticia Castrillo, Anthony Salazar, Mercè Roqué, Ana Paula Dantas, Manel Sabaté, Salvatore Brugaletta · 2021 · Journal of Clinical Medicine
71. Papel del sistema inmune en la infección por el SARS-CoV-2: inmunopatología de la COVID-19
    J. Monserrat Sanz, Ana Maria Gomez-Lahoz, R. Oliva Martín · 2021 · Medicine - Programa de Formación Médica Continuada Acreditado
72. A predictive paradigm for COVID-19 prognosis based on the longitudinal measure of biomarkers
    Xin Chen, Wei Gao, Jie Li, Dongfang You, Zhaolei Yu, Mingzhi Zhang, Fang Shao, Yongyue Wei, Ruyang Zhang, Theis Lange et al. · 2021 · Briefings in Bioinformatics
73. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells
    Min Kyung Jung, Eui‐Cheol Shin · 2021 · Molecules and Cells
74. Effects of antiviral drug therapy on dynamic thiol/disulphide homeostasis and nitric oxide levels in COVID-19 patients
    Ayşe Özlem Mete, Kübra Koçak, Ahmet Saracaloğlu, Şeniz Demiryürek, Özgür Altınbaş, Abdullah Tuncay Demiryürek · 2021 · European Journal of Pharmacology
75. Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms
    Julien Brechbühl, Ana Catarina Lopes, Dean Wood, Sofiane Bouteiller, Aurélie de Vallière, Chantal Verdumo, Marie-Christine Broillet · 2021 · Communications Biology
76. SARS-CoV-2 and Acute Cerebrovascular Events: An Overview
    Mehdi Ghasemi, Raffaella Pizzolato Umeton, Kiandokht Keyhanian, Babak Mohit, Nasrin Rahimian, Niloofarsadaat Eshaghhosseiny, Vahid Davoudi · 2021 · Journal of Clinical Medicine
77. Management of Patients With Glucocorticoid-Related Diseases and COVID-19
    Irina Oana Chifu, Mario Detomas, Ulrich Dischinger, Otilia Kimpel, Felix Megerle, Stefanie Hahner, Martin Faßnacht, Barbara Altieri · 2021 · Frontiers in Endocrinology
78. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
    Yanlan Xu, Xinyu Yang, Hua Bian, Mingfeng Xia · 2021 · Lipids in Health and Disease
79. Mechanisms and management of prothrombotic state in COVID-19 disease
    Trishna Acherjee, Aparna Behara, Muhammad Saad, Timothy J. Vittorio · 2021 · Therapeutic Advances in Cardiovascular Disease
80. Identification of Endotypes of Hospitalized COVID-19 Patients
    Benjamin L. Ranard, Murad Megjhani, Kalijah Terilli, Kevin William Doyle, Jan Claassen, Michael R. Pinsky, Gilles Clermont, Yoram Vodovotz B, Shadnaz Asgari, Soojin Park · 2021 · Frontiers in Medicine
81. Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients
    Lenar Yessayan, Javier A. Neyra, Angela J. Westover, Balázs Szamosfalvi, Harvey David Humes · 2022 · Critical Care Explorations
82. Lectin Pathway Enzyme MASP-2 and Downstream Complement Activation in COVID-19
    Maximilian Peter Götz, Mikkel‐Ole Skjoedt, Rafael Bayarri‐Olmos, Cecilie Bo Hansen, Laura Pérez‐Alós, Ida Jarlhelt, Thomas Benfield, Anne Rosbjerg, Peter Garred · 2022 · Journal of Innate Immunity
83. Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
    Daniela Latorre · 2022 · European Journal of Immunology
84. Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID ‐19 pneumonia: An open‐label randomised trial
    Luís Corral-Gudino, Iván Cusácovich, José Ignacio Martín‐González, Alberto Muela Molinero, Jessica Abadía Otero, Roberto González‐Fuentes, Ángela Ruiz de Temiño, Elena Tapia Moral, Francisca Cuadrado‐Medina, Miguel Martín Asenjo et al. · 2022 · European Journal of Clinical Investigation
85. Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia
    Frances Linzee Mabrey, Hui Nian, Chang Yu, Elizabeth M. Barnes, Uma Malhotra, Carmen R. Mikacenic, Julia Goldstein, D. Shane O’Mahony, Julia Garcia‐Diaz, Patricia W. Finn et al. · 2023 · EBioMedicine
86. COVID-19 pandemic sheds a new research spotlight on antiviral potential of essential oils – A bibliometric study
    Binawati Ginting, Williams Chiari, Teuku Fais Duta, Syihaabul Hudaa, Agnia Purnama, Harapan Harapan, Diva Rayyan Rizki, Kana Puspita, Rinaldi Idroes, Meriatna Meriatna et al. · 2023 · Heliyon
87. The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection
    Déborah Lécuyer, Roberta Nardacci, Désirée Tannous, Emie Gutierrez-Mateyron, Aurélia Deva Nathan, Frédéric Subra, Cristina Di Primio, Paola Quaranta, Vanessa Petit, Clémence Richetta et al. · 2023 · Frontiers in Immunology
88. The association between various viral infections and multiple sclerosis: An umbrella review on systematic review and meta‐analysis
    Arash Bakhshi, Narges Eslami, Naeim Norouzi, Negin Letafatkar, Ehsan Amini‐Salehi, Soheil Hassanipour · 2023 · Reviews in Medical Virology
89. Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19
    Alaa Elsaghir, Ehsan M. W. El-Sabaa, Asmaa Mohamed Zahran, Sahar A. Mandour, Eman Hassan Ali Salama, Sahar Aboulfotuh, Reham Mohammed El-morshedy, Stefania Tocci, Ahmed Mandour, Wael Esmat Ali et al. · 2023 · International Journal of Molecular Sciences
90. Understanding COVID-19: From Origin to Potential Therapeutics
    Muhammad Moazzam, M. Sajid, H. Shahid, J. Butt, I. Bashir, M. Jamshaid, A. Shirazi, R. Tiwari · 2020 · International Journal of Environmental Research and Public Health
91. Evolutionary medical insights into the SARS-CoV-2 pandemic
    Bernard J. Crespi · 2020 · Evolution Medicine and Public Health
92. Mild anemia as a single independent predictor of mortality in patients with COVID‐19
    Douglas A. Tremblay, Joseph L. Rapp, Naomi Alpert, Wil Lieberman‐Cribbin, John O Mascarenhas, Emanuela Taioli, Saghi Ghaffari · 2021 · eJHaem
93. Evaluating the effects of cardiometabolic exposures on circulating proteins which may contribute to severe SARS-CoV-2
    Tom G. Richardson, Si Fang, Ruth E. Mitchell, Michael Vaclav Holmes, George Davey Smith · 2021 · EBioMedicine
94. SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals
    Min‐Seok Rha, A Reum Kim, Eui‐Cheol Shin · 2021 · Immune Network
95. Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus?
    Rodrigo N. Riedel, Antonio Pérez‐Pérez, Víctor Sánchez‐Margalet, Cecilia Laura Varone, Julieta Lorena Maymó · 2021 · Stem Cell Research & Therapy
96. Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19
    Clarissa Stephanie Santoso, Zhaorong Li, Jaice T. Rottenberg, Xing Liu, Vivian X. Shen, Juan I. Fuxman Bass · 2021 · Frontiers in Pharmacology
97. Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review
    Zemene Demelash Kifle · 2021 · Metabolism Open
98. 124I-Iodo-DPA-713 Positron Emission Tomography in a Hamster Model of SARS-CoV-2 Infection
    Camilo A. Ruiz-Bedoya, Filipa Mota, Alvaro A. Ordoñez, Catherine A. Foss, Alok Kumar Singh, Monali Praharaj, Farina J. Mahmud, Ali Ghayoor, Kelly Flavahan, Patricia De Jesus et al. · 2021 · Molecular Imaging and Biology
99. Pyruvate Kinase M2 Nuclear Translocation Regulate Ferroptosis-Associated Acute Lung Injury in Cytokine Storm
    Haiting Wang, Chenyu Fan, Xuelian Chen, Wei Zhou, Li Guo, Feng Zhao, Shuang Ye, Shuangjun He, Yi Chen · 2024 · Inflammation
100. SARS-CoV-2 inflammation durably imprints memory CD4 T cells
     Sophie L. Gray-Gaillard, Sabrina M. Solis, Han M. Chen, Clarice Monteiro, Grace O. Ciabattoni, Marie I. Samanovic, Amber R. Cornelius, Tijaana Williams, Emilie Geesey, Miguel Rodriguez et al. · 2024 · Science Immunology